• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,450.14 -258.38
( -0.33%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541540
INE624Z01016
263.4170323
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SOLARA
0
2724.89
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

SJVN reports consolidated net loss of Rs 117.98 crore in the March 2026 quarter
May 15,2026
Net Loss of SJVN reported to Rs 117.98 crore in the quarter ended March 2026 as against net loss of Rs 127.60 crore during the previous quarter ended March 2025. Sales rose 196.68% to Rs 1496.47 crore in the quarter ended March 2026 as against Rs 504.40 crore during the previous quarter ended March 2025.

For the full year,net profit declined 21.67% to Rs 642.08 crore in the year ended March 2026 as against Rs 819.66 crore during the previous year ended March 2025. Sales rose 47.40% to Rs 4528.29 crore in the year ended March 2026 as against Rs 3072.01 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1496.47504.40 197 4528.293072.01 47
OPM %60.7947.76 -72.7171.88 -
PBDT447.75133.52 235 2189.351775.09 23
PBT-46.64-141.51 67 1147.371098.88 4
NP-117.98-127.60 8 642.08819.66 -22